Special Commentary: Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014

Affiliations

¹ Department of Ophthalmology, Jules Stein Eye Institute, UCLA David Geffen School of Medicine, Los Angeles, California.
² Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
³ Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
⁴ Department of Ophthalmology, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania.
⁵ Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida.
⁶ Minnesota Eye Consultants, Minneapolis, Minnesota.
⁷ Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
⁸ Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland. Electronic address: malvina.eydelman@fda.hhs.gov.

Joseph Caprioli et al. Ophthalmology. 2015 Sep.

. 2015 Sep;122(9):1795-801.

doi: 10.1016/j.ophtha.2015.02.029. Epub 2015 Apr 14.

¹ Department of Ophthalmology, Jules Stein Eye Institute, UCLA David Geffen School of Medicine, Los Angeles, California.
² Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland.
³ Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
⁴ Department of Ophthalmology, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania.
⁵ Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida.
⁶ Minnesota Eye Consultants, Minneapolis, Minnesota.
⁷ Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
⁸ Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland. Electronic address: malvina.eydelman@fda.hhs.gov.

No abstract available

Comment in

MIGS and the FDA: What's in a Name?
Ahmed II. Ahmed II. Ophthalmology. 2015 Sep;122(9):1737-9. doi: 10.1016/j.ophtha.2015.06.022. Ophthalmology. 2015. PMID: 26299720 No abstract available.